Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in bare lymphocyte syndrome.
Open Access
- 1 June 1994
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 179 (6) , 2017-2022
- https://doi.org/10.1084/jem.179.6.2017
Abstract
The human immunodeficiency, type II bare lymphocyte syndrome (BLS), has been attributed to a defect in the transcription of class II histocompatibility genes. Immunocompetence, as assessed by functional exogenous antigen presentation, was not restored in immortalized B cells, derived from a BLS patient, after transfection with HLA-DR class II structural genes. Incubation of protein antigens, as well as infectious virus, with DR-transfected BLS cells failed to induce activation of antigen-specific helper T lymphocytes. Peptide antigens were presented by class II molecules displayed on BLS cells, although the conformation of these class II proteins was altered as indicated by epitope mapping. This defect in antigen presentation was independent of the specific class II DR allele transfected into BLS cells. Genetic complementation analysis has been used with BLS cells to demonstrate that the defect in class II gene transcription is linked to the absence of a trans-acting factor. Similarly, functional class II dimers were restored after in vitro fusion of cells derived from two distinct BLS complementation groups, implying that specific transcriptional control elements are shared by a gene critical for antigen presentation and genes encoding HLA class II antigens. Thus, two important functionally linked pathways of class II molecules, structural gene expression and antigen presentation, share a common regulatory pathway defective in BLS.Keywords
This publication has 20 references indexed in Scilit:
- The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.The Journal of Immunology, 1992
- Genetic complexity of regulatory mutants defective for HLA class II gene expression.The Journal of Immunology, 1992
- A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex.The Journal of Experimental Medicine, 1991
- Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.The Journal of Immunology, 1991
- Regulation of the class II-associated invariant chain gene in normal and mutant B lymphocytes.Proceedings of the National Academy of Sciences, 1990
- Bare lymphocyte syndrome: Altered HLA class II expression in B cell lines derived from two patientsHuman Immunology, 1989
- A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.Journal of Clinical Investigation, 1985
- Genes regulating HLA class I antigen expression in T-B lymphoblast hybridsImmunogenetics, 1985
- Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3The Journal of Experimental Medicine, 1982
- Two populations of Ia-like molecules on a human B cell line.The Journal of Immunology, 1980